Mutagenesis of the BH3 domain of BAX identifies residues critical for dimerization and killing

Molecular and Cellular Biology

Volumn 18, Issue 10, 1998, Pages 6083-6089

  Wang, Kun ^a   Gross, Atan ^a   Waksman, Gabriel ^a   Korsmeyer, Stanley J ^a,b  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b DANA FARBER CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMAL CELL; APOPTOSIS; ARTICLE; CELL DEATH; CONTROLLED STUDY; DELETION MUTANT; DIMERIZATION; GENE STRUCTURE; MITOCHONDRIAL MEMBRANE; NONHUMAN; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN LOCALIZATION; RAT; SITE DIRECTED MUTAGENESIS; STRUCTURE ACTIVITY RELATION;

ANIMALIA; GENETTA;

EID: 0031660082     PISSN: 02707306     EISSN: None     Source Type: Journal    
DOI: 10.1128/MCB.18.10.6083     Document Type: Article

References (29)

1. Antonsson, B., F. Conti, A. Ciavatta, S. Montessuit, S. Lewis, I. Martinou, L. Bernasconi, A. Bernard, J.-J. Mermod, G. Mazzei, K. Maundrell, F. Gambale, R. Sadoul, and J.-C. Martinou. 1997. Inhibition of Bax channel-forming activity by Bcl-2. Science 277:370-372.
2. L. Nature 379:554-556.
3. Chittenden, T., C. Flemington, A. B. Houghton, G. E. Ebb, G. J. Gallo, B. Elangovan, G. Chinnadurai, and R. J. Lutz. 1995. A conserved domain in Bak, distinct from BH1 and BH2, mediates cell death and protein binding functions. EMBO J. 14:5589-5596.
4. Diaz, J.-L., T. Oltersdorf, W. Horne, M. McConnell, G. Wilson, S. Weeks, T. Garcia, and L. C. Fritz. 1997. A common binding site mediates heterodimerization and homodimerization of Bcl-2 family members. J. Biol. Chem. 272:11350-11355.
5. Farrow, S. N., and R. Brown. 1996. New members of the Bcl-2 family and their protein partners. Curr. Opin. Genet. Dev. 6:45-49.
6. Gross, A., J. Jockei, M. Wei, and S. J. Korsmeyer. 1998. Enforced dimerization of BAX results in its translocation, mitochondrial dysfunction and apoptosis. EMBO J. 17:3878-3885.
7. Han, J., P. Sabbatini, D. Perez, L. Rao, D. Modha, and E. White. 1996. The E1B 19K protein blocks apoptosis by interacting with and inhibiting the p53-inducible and death-promoting Bax protein. Genes Dev. 10:461-477.
8. L during apoptosis. Proc. Natl. Acad. Sci. USA 94:3668-3672.
9. Hunter, J. J., and T. G. Parslow. 1996. A peptide sequence from Bax that converts Bcl-2 into an activator of apoptosis. J. Biol. Chem. 271:8521-8524.
10. Knudson, C. M., and S. J. Korsmeyer. 1997. Bcl-2 and Bax function independently to regulate cell death. Nat. Genet. 16:358-363.
11. Kroemer, G. 1997. The proto-oncogene Bcl-2 and its role in regulating apoptosis. Nat. Med. 3:614-620.
12. Meijerink, J. P. P., E. J. B. M. Mensink, K. Wang, T. W. Sedlak, A. W. Sloetjes, T. de Witte, and S. J. Korsmeyer. 1997. Hematopoietic malignancies demonstrate loss-of-function mutations of BAX. Blood 91:2991-2997.
13. L, an inhibitor of programmed cell death. Nature 381:335-341.
14. Oltvai, Z. N., C. L. Milliman, and S. J. Korsmeyer. 1993. Bcl-2 heterodimerizes in vivo with a conserved homolog, Bax, that accelerates programmed cell death. Cell 74:609-619.
15. Sabine, O., J.-L. Dias, J. Chang, G. Wilson, K. M. Tuffo, S. Weeks, M. McConnell, Y. Wang, T. Oltersdorf, and L. C. Fritz. 1997. Structural and functional complementation of an inactive Bcl-2 mutant by Bax truncation. J. Biol. Chem. 272:16955-16961.
16. Sato, T., M. Hanada, S. Bodrug, S. J. Irie, N. Iwama, L. H. Boise, C. B. Thompson, E. Golemis, L. Fong, H. G. Wang, and J. C. Reed. 1994. Interactions among members of the Bcl-2 protein family analyzed with a yeast two-hybrid system. Proc. Natl. Acad. Sci. USA 91:9238-9242.
17. L-Bak peptide complex: recognition between regulators of apoptosis. Science 275:983-986.
18. Schlesinger, P. H., A. Gross, X.-M. Yin, K. Yamamoto, M. Saito, G. Waksman, and S. J. Korsmeyer. 1997. Comparison of the ion channel characteristics of proapoptotic BAX and antiapoptotic BCL-2. Proc. Natl. Acad. Sci. USA 94:11357-11362.
19. Sedlak, T. W., Z. Oltvai, E. Yang, L. H. Boise, C. B. Thompson, and S. J. Korsmeyer. 1995. Multiple Bcl-2 family members demonstrate selective dimerizations with Bax. Proc. Natl. Acad. Sci. USA 92:7834-7838.
20. 19a.Sedlak, T. W., and S. J. Korsmeyer. Unpublished observations.
21. Simonian, P. L., D. A. M. Grillot, D. W. Andrews, B. Leber, and G. Nuñez. 1996. Bax homodimerization is not required for Bax to accelerate chemotherapy-induced cell death. J. Biol. Chem. 271:32073-32077.
22. L. J. Biol. Chem. 271: 22764-22772.
23. Steller, H. 1995. Mechanisms and genes of cellular suicide. Science 267: 1445-1449.
24. Wang, K., X.-M. Yin, D. T. Chao, C. L. Milliman, and S. J. Korsmeyer. 1996. BID: a novel BH3 domain-only death agonist. Genes Dev. 10:2859-2869.
25. Wolter, K. G., Y.-T. Hsu, C. L. Smith, A. Nechushtan, X.-G. Xi, and R. J. Youle. 1997. Movement of Bax from the cytosol to mitochondria during apoptosis. J. Cell Biol. 139:1281-1292.
26. Xiang, J., D. T. Chao, and S. J. Korsmeyer. 1996. Bax-induced cell death may not require interleukin 1 beta-converting enzyme-like proteases. Proc. Natl. Acad. Sci. USA 93:14559-14563.
27. Yin, X. M., Z. N. Oltvai, and S. J. Korsmeyer. 1994. BH1 and BH2 domains of Bcl-2 are required for inhibition of apoptosis and heterodimerization with Bax. Nature 369:321-323.
28. Zha, H., and J. C. Reed. 1997. Heterodimerization-independent functions of cell death regulatory proteins Bax and Bcl-2 in yeast and mammalian cells. J. Biol. Chem. 272:31482-31488.
29. Zha, H., C. Aime-Sempe, T. Sato, and J. C. Reed. 1996. Proapoptotic protein Bax heterodimerizes with Bcl-2 and homodimerizes with Bax via a novel domain (BH3) distinct from BH1 and BH2. J. Biol. Chem. 271:7440-7444.